Project description DEENESFRITPL Artificial intelligence to support early prostate cancer diagnostics Prostate cancer is the most common type of cancer in men and their second leading cause of death; however, it is highly treatable in the early stages. Recent studies and clinical trials have demonstrated the efficiency of prostate MRI in early diagnosis, with 5 times less missed cancer cases and 25 % fewer biopsies. Care standards now recommend MRI prior to every biopsy, leading to an increased demand for prostate MRI scans. Conventional radiology reading capacity cannot keep pace with the demand. Quantib BV (Netherlands) developed an AI-enhanced integrated diagnostic solution for the detection of potential tumors and workflow optimization involving urologists, radiologists and pathologists. The current EU-funded ID-PROSTATE project allows further improvement and acceleration focusing on product commercialization. Show the project objective Hide the project objective Objective Quantib Prostate is an AI-enhanced solution to enable an integrated diagnostic care pathway for prostate cancer between urologist, radiologist and pathologist. Prostate cancer is the most prevalent form of cancer in men and their second leading cause of death. Recent high-impact clinical trials have demonstrated the utility of prostate MRI in the care-pathway: 5x fewer missed cancers, 25% fewer biopsies. These trials resulted in changes in care standards per 2019, now recommending MRI prior to every biopsy, resulting in a strong demand increase for prostate MRI scans.Conventional radiology reading capacity cannot keep pace with that demand due to long staff training times. Quantib Prostate addresses this issue with AI-algorithms that detect potential tumors and workflow enhancements that reduce reporting time.This project allows Quantib to accelerate and further improve Quantib Prostate. Fields of science medical and health sciencesclinical medicineoncologyprostate cancerengineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Keywords Prostate Cancer Deep Learning Radiomics Image-based Diagnosis MRI Pathology Medical Image Analysis Quantitative Imaging Biomarkers Integrated Diagnostics Radiology Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-EIC-SMEInst-2018-2020-3 Funding Scheme SME-2 - SME instrument phase 2 Coordinator QUANTIB BV Net EU contribution € 2 100 371,88 Address Westblaak 130 3012 KM Rotterdam Netherlands See on map Region West-Nederland Zuid-Holland Groot-Rijnmond Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 900 159,37
